Latest Breaking News On - Keith aqua - Page 1 : comparemela.com

Validcare Selected By Emerging Biotech, Coologics, To Lead Women's Health Study

Impact Naturals' Cannabidiol (CBD) Products Demonstrate Strong Safety Data in Landmark Study

/PRNewswire/ The largest-scale consumer safety study to date shows orally ingested cannabidiol (CBD) is safe for daily consumption. Results from a.

Tauriga Sciences, Inc. Initiates Clinical Trial to Examine the Effects of Cannabidiol Doses on Pregnant Women with Diagnosis of Hyperemesis Gravidarum

Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA

Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA Share Article Validcare s Decentralized Clinical Trial Allows for Consumer Participation During COVID We are excited to have our state of the art, decentralized trial technology overcome the hurdles of performing research during a pandemic. DENVER (PRWEB) April 15, 2021 Validcare announced today the addition of a second cohort of CBD brands participating in a large scale, human safety study, a significant and widescale endeavor to answer the FDA’s call for additional safety data. This second cohort expands the reliability of Validcare’s recently completed findings in Cohort 1 regarding liver safety in healthy adults ingesting either full or broad-spectrum hemp-derived CBD. The study is designed to respond to the FDA’s repeated requests, including the Agency’s March 5, 2020 report to Congress for science-based da

Study: No evidence of liver toxicity from use of CBD from hemp

Study: No evidence of liver toxicity from use of CBD from hemp Investigators report to FDA no evidence of liver toxicity in 839 adults consuming oral CBD Published:  Updated:  Tags:  CBD products Researchers presented initial results from a study to the FDA in March suggesting there is no evidence of liver disease from the use of hemp-derived CBD products. The study, conducted by a team from clinical research company Validcare, aims to help the FDA to determine how to appropriately regulate CBD products. CBD, short for cannabidiol, comes from the cannabis plant. It is one of two most commonly known compounds of cannabis (marijuana), the other being delta-9-tetrahydrocannabinol (THC). It’s the THC that is associated with a “high,” not CBD.